価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CD130, Mouse-Mono(B-S12), Azide free <Anti-gp130>
データシート※最新のデータシートでない場合があります
852.110.000 TLSダイアクローン
Diaclone SAS
200 μl 本製品は取扱中止になりました 追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-CD130, Mouse-Mono(B-S12), Azide free <Anti-gp130>

  • 商品コード:852.110.000
  • メーカー:TLS
  • 包装:200μl
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Lebeau B et al. Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett. 1997 Apr;407(2):141-7
Lebeau B et al
1997/01/01
Application: activation of gp130 PubMed
2 Ancey C et al. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. Cardiovasc. Res. 2003 Jul;59(1):78-85
Ancey C et al
2003/01/01
Application: Agonistic activity on gp130 PubMed
3 Hammacher A et al. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J. Biol. Chem. 1998 Aug;273(35):22701-7
Hammacher A et al
1998/01/01
Application: FC PubMed
4 Kube D et al. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001 Aug;98(3):762-70
Kube D et al
2001/01/01
Application: FC PubMed
5 Kurth I et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 2000 Jan;164(1):273-82
Kurth I et al
2000/01/01
Application: FC PubMed
6 Voisin MB et al. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation. J. Biol. Chem. 2002 Apr;277(16):
Voisin MB et al
2002/01/01
Application: FC PubMed
7 Kallen KJ et al. Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6. J. Biol. Chem. 1999 Apr;274(17):11859-67
Kallen KJ et al
1999/01/01
Application: FC, IP PubMed
8 Autissier P et al. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb. Int. Immunol. 1998 Dec;10(12):1881-9
Autissier P et al
1998/01/01
Application: gp130 activation PubMed
9 Fourcin M et al. gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses. J. Biol. Chem. 1996 May;271(20):11756-60
Fourcin M et al
1996/01/01
Application: gp130 activation PubMed
10 Giese B et al. Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. J. Biol. Chem. 2003 Oct;278(40):39205-13
Giese B et al
2003/01/01
Application: gp130 activation PubMed
11 Gu ZJ et al. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors. Leukemia 2000 Jan;14(1):188-97
Gu ZJ et al
2000/01/01
Application: gp130 activation PubMed
12 Hammacher A et al. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors. Biochem. J. 2000 Jan;345 Pt 1:25-32
Hammacher A et al
2000/01/01
Application: gp130 activation PubMed
13 Jover R et al. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. 2002 Nov;16(13):1799-801
Jover R et al
2002/01/01
Application: gp130 activation PubMed
14 M端ller-Newen G et al. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J. Biol. Chem. 2000 Feb;275(7):4579-86
M端ller-Newen G et al
2000/01/01
Application: gp130 activation PubMed
15 Puthier D et al. Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone. Blood 1996 Dec;88(12):4659-66
Puthier D et al
1996/01/01
Application: gp130 activation PubMed
16 Wang YD et al. gp130-linked signal transduction promotes the differentiation and maturation of dendritic cells. Int. Immunol. 2002 Jun;14(6):599-603
Wang YD et al
2002/01/01
Application: gp130 activation PubMed
17 Rebouissou C et al. A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma. Blood 1998 Jun;91(12):4727-37
Rebouissou C et al
1998/01/01
Application: gp130 activation and FC PubMed
18 Horsten U et al. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J. Biol. Chem. 1997 Sep;272(38):23748-57
Horsten U et al
1997/01/01
Application: gp130 activation, FC and primary antibody in immunoflouresence PubMed
19 Kurth I et al. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J. Immunol. 1999 Feb;162(3):1480-7
Kurth I et al
1999/01/01
Application: Immunoflourescent staining PubMed
20 Thiel S et al. Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem. J. 1998 Feb;330 ( Pt 1):47-54
Thiel S et al
1998/01/01
Application: Immunoflourescent staining, GP130 internalisation studies, STAT1/3 activation PubMed
21 Selander KS et al. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res. 2004 Oct;64(19):6924-33
Selander KS et al
2004/01/01
Application: IP PubMed
22 Ancey C et al. Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine 2002 May;18(4):199-205
Ancey C et al
2002/01/01
Application: stimulation of IL-6 secretion PubMed
23 Olivier C et al. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response. J. Biol. Chem. 2000 Feb;275(8):5648-56
Olivier C et al
2000/01/01
PubMed
24 Simpson RJ et al. Interleukin-6: structure-function relationships. Protein Sci. 1997 May;6(5):929-55
Simpson RJ et al
1997/01/01
PubMed
  • No.: 1
  • 文献情報:
    Lebeau B et al. Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett. 1997 Apr;407(2):141-7
    Lebeau B et al
    1997/01/01
  • 備考:
    Application: activation of gp130
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ancey C et al. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. Cardiovasc. Res. 2003 Jul;59(1):78-85
    Ancey C et al
    2003/01/01
  • 備考:
    Application: Agonistic activity on gp130
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hammacher A et al. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J. Biol. Chem. 1998 Aug;273(35):22701-7
    Hammacher A et al
    1998/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kube D et al. STAT3 is constitutively activated in Hodgkin cell lines. Blood 2001 Aug;98(3):762-70
    Kube D et al
    2001/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kurth I et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 2000 Jan;164(1):273-82
    Kurth I et al
    2000/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Voisin MB et al. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation. J. Biol. Chem. 2002 Apr;277(16):
    Voisin MB et al
    2002/01/01
  • 備考:
    Application: FC
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kallen KJ et al. Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6. J. Biol. Chem. 1999 Apr;274(17):11859-67
    Kallen KJ et al
    1999/01/01
  • 備考:
    Application: FC, IP
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Autissier P et al. Dimerization and activation of the common transducing chain (gp130) of the cytokines of the IL-6 family by mAb. Int. Immunol. 1998 Dec;10(12):1881-9
    Autissier P et al
    1998/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Fourcin M et al. gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses. J. Biol. Chem. 1996 May;271(20):11756-60
    Fourcin M et al
    1996/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Giese B et al. Long term association of the cytokine receptor gp130 and the Janus kinase Jak1 revealed by FRAP analysis. J. Biol. Chem. 2003 Oct;278(40):39205-13
    Giese B et al
    2003/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Gu ZJ et al. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors. Leukemia 2000 Jan;14(1):188-97
    Gu ZJ et al
    2000/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Hammacher A et al. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors. Biochem. J. 2000 Jan;345 Pt 1:25-32
    Hammacher A et al
    2000/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Jover R et al. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. 2002 Nov;16(13):1799-801
    Jover R et al
    2002/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    M端ller-Newen G et al. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J. Biol. Chem. 2000 Feb;275(7):4579-86
    M端ller-Newen G et al
    2000/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Puthier D et al. Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone. Blood 1996 Dec;88(12):4659-66
    Puthier D et al
    1996/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Wang YD et al. gp130-linked signal transduction promotes the differentiation and maturation of dendritic cells. Int. Immunol. 2002 Jun;14(6):599-603
    Wang YD et al
    2002/01/01
  • 備考:
    Application: gp130 activation
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Rebouissou C et al. A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma. Blood 1998 Jun;91(12):4727-37
    Rebouissou C et al
    1998/01/01
  • 備考:
    Application: gp130 activation and FC
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Horsten U et al. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J. Biol. Chem. 1997 Sep;272(38):23748-57
    Horsten U et al
    1997/01/01
  • 備考:
    Application: gp130 activation, FC and primary antibody in immunoflouresence
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kurth I et al. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J. Immunol. 1999 Feb;162(3):1480-7
    Kurth I et al
    1999/01/01
  • 備考:
    Application: Immunoflourescent staining
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Thiel S et al. Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway. Biochem. J. 1998 Feb;330 ( Pt 1):47-54
    Thiel S et al
    1998/01/01
  • 備考:
    Application: Immunoflourescent staining, GP130 internalisation studies, STAT1/3 activation
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Selander KS et al. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res. 2004 Oct;64(19):6924-33
    Selander KS et al
    2004/01/01
  • 備考:
    Application: IP
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Ancey C et al. Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine 2002 May;18(4):199-205
    Ancey C et al
    2002/01/01
  • 備考:
    Application: stimulation of IL-6 secretion
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Olivier C et al. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response. J. Biol. Chem. 2000 Feb;275(8):5648-56
    Olivier C et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Simpson RJ et al. Interleukin-6: structure-function relationships. Protein Sci. 1997 May;6(5):929-55
    Simpson RJ et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed